Chinese government advisers expect limited economic hit from U.S. trade rift
BOAO, China (Reuters) – Chinese state researchers and media have talked down the likely impact of U.S. trade measures on the world’s second largest economy and described the Trump administration’s posturing on trade as the product of an “anxiety disord…
Tesla to recall 8,898 vehicles in China from June 28: China quality watchdog
BEIJING (Reuters) – China’s quality watchdog said on Monday that Tesla Inc will recall a total of 8,898 Model S vehicles in the country starting on June 28, as part of a broader, global recall announced last month.
Shares in Telecom Italia volatile ahead of board meeting
MILAN (Reuters) – Shares in Telecom Italia dropped as much as 5 percent before paring losses on Monday as a battle continues among key shareholders in the Italian phone group.
Novartis bets big on gene therapy with $8.7 billion AveXis deal
ZURICH (Reuters) – Swiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales.
Deutsche Bank’s new CEO plans investment banking review
FRANKFURT (Reuters) – Deutsche Bank’s leadership must take tough decisions to avoid further setbacks and will review the structure of its investment bank, new CEO Christian Sewing told staff on Monday.
China joins HK-U.S. battle for Chinese tech listings
HONG KONG (Reuters) – When Charles Li, chief executive of the Hong Kong Exchange, last year announced plans to help the next wave of Chinese tech giants go public in the city, bankers celebrated.
Asia rallies with S&P futures; confused on Syria
SYDNEY (Reuters) – Asian shares crept higher on Monday as a rally in U.S. stock futures soothed sentiment even as U.S. President Donald Trump kept up his twitter war with China just a couple of days before President Xi Jinping gives a keynote speech.
Novartis shells out $8.7 billion to buy AveXis
ZURICH (Reuters) – Novartis said on Monday it plans to buy AveXis for $218 per share in a cash deal totaling $8.7 billion as the Swiss drugmaker adds a company whose top drug hopeful, for spinal muscular atrophy, has U.S. breakthrough therapy designa…
Tech group urges U.S. to recruit allies to take on China, not tariffs
WASHINGTON (Reuters) – A trade group representing top technology companies on Monday told U.S. Treasury Secretary Steven Mnuchin that it opposes the Trump administration’s focus on tariffs to try to change China’s unfair trade practices.
Rusal shares plunge over 40 percent on U.S. sanctions
HONG KONG (Reuters) – Shares of Russian aluminum giant United Company Rusal Plc plunged as much as 41.8 percent on Monday as investors bailed on the stock after it was included in a new list of U.S. sanctions targeting Russian companies and their owne…
